The challenge of diagnosing a mixed asthma-COPD phenotype (ACOS) in clinical practice

Ther Adv Respir Dis. 2016 Apr;10(2):175-8. doi: 10.1177/1753465816630209.

Authors

María del Carmen García-García¹, Jacinto Hernández-Borge¹, Miriam Barrecheguren², Marc Miravitlles³

Affiliations

¹ Pneumology Department, Complejo Hospitalario Universitario Infanta Cristina, Badajoz, Spain.
² Pneumology Department, Hospital General Universitari Vall d'Hebron, Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain.
³ Pneumology Department, Hospital General Universitari Vall d'Hebron, P. Vall d'Hebron 119-129, 08035, Barcelona, Spain mmiravitlles@vhebron.net.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adrenal Cortex Hormones / therapeutic use
Adrenergic beta-2 Receptor Agonists / therapeutic use
Aged
Aged, 80 and over
Anti-Asthmatic Agents / therapeutic use
Asthma / complications
Asthma / diagnosis*
Asthma / drug therapy
Asthma / physiopathology
Bronchodilator Agents / therapeutic use
Disease Progression
Female
Humans
Lung / drug effects
Lung / physiopathology*
Male
Middle Aged
Phenotype
Pulmonary Disease, Chronic Obstructive / complications
Pulmonary Disease, Chronic Obstructive / diagnosis*
Pulmonary Disease, Chronic Obstructive / drug therapy
Pulmonary Disease, Chronic Obstructive / physiopathology
Syndrome
Treatment Outcome

Substances

Adrenal Cortex Hormones
Adrenergic beta-2 Receptor Agonists
Anti-Asthmatic Agents
Bronchodilator Agents